GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,097,000 | +20.8% | 71,111 | +20.9% | 0.03% | -15.0% |
| Q1 2022 | $2,563,000 | +544.0% | 58,836 | +555.4% | 0.04% | +566.7% |
| Q4 2021 | $398,000 | -48.2% | 8,977 | -56.0% | 0.01% | -81.2% |
| Q3 2020 | $768,000 | +190.9% | 20,398 | +229.6% | 0.03% | +113.3% |
| Q3 2019 | $264,000 | -55.3% | 6,188 | -56.2% | 0.02% | -62.5% |
| Q1 2019 | $591,000 | -11.5% | 14,139 | -19.2% | 0.04% | -11.1% |
| Q4 2018 | $668,000 | -14.9% | 17,493 | -10.5% | 0.04% | -16.7% |
| Q3 2018 | $785,000 | -0.1% | 19,542 | +0.2% | 0.05% | -6.9% |
| Q2 2018 | $786,000 | +29.7% | 19,501 | +25.8% | 0.06% | +26.1% |
| Q1 2018 | $606,000 | -8.0% | 15,498 | -16.6% | 0.05% | +4.5% |
| Q4 2017 | $659,000 | -38.8% | 18,581 | -29.9% | 0.04% | -42.1% |
| Q3 2017 | $1,076,000 | +101.5% | 26,506 | +114.1% | 0.08% | +68.9% |
| Q2 2017 | $534,000 | +3.5% | 12,378 | +1.2% | 0.04% | +4.7% |
| Q1 2017 | $516,000 | – | 12,234 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |